Form 8-K - Current report:
SEC Accession No. 0001477932-21-002704
Filing Date
2021-04-29
Accepted
2021-04-29 09:15:33
Documents
1
Period of Report
2021-04-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K curr_8k.htm 8-K 14894
  Complete submission text file 0001477932-21-002704.txt   16125
Mailing Address 1620 BEACON PLACE OXNARD CA 93033
Business Address 1620 BEACON PLACE OXNARD CA 93033 805-824-0410
Cure Pharmaceutical Holding Corp. (Filer) CIK: 0001643301 (see all company filings)

IRS No.: 371765151 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55908 | Film No.: 21867452
SIC: 2834 Pharmaceutical Preparations